Part 1: Dr. Michael Lederman - Wolstein
Michael M. Lederman, M.D.Scott R Inkley Professor of Medicine
Director, Case/University Hospitals Center for AIDS Research
Principle Investigator, Case/UH AIDS Clinical Trials Unit
"Prevention in HIV Infection: Is there any hope?"
Friday, October 10, 2008
12:30 - 1:45pm, lunch provided.
Wolstein Research Building Auditorium (Room 1413)
Research
Michael Lederman is the Scott R. Inkley Professor of Medicine at Case Western Reserve University School of Medicine and University Hospitals of Cleveland where he is also Professor of Biomedical Ethics, Pathology, Microbiology and Molecular Biology. Dr. Lederman is the Principal Investigator of the CWRU/UH AIDS Clinical Trials Unit and Associate Director of the Center for AIDS Research.
Dr. Lederman has been engaged in HIV/AIDS research since he and Dr. Oscar Ratnoff first described and characterized the occurrence of AIDS-related immune deficiency in otherwise healthy men with hemophilia in 1983. The author of numerous peer-reviewed scientific publications, Dr. Lederman's research has focused on the mechanisms whereby HIV infection induces immune deficiency and strategies to correct and prevent it. He has also been a leader in research on the development of an effective HIV microbicide, an increasingly important strategy to prevent new HIV infections.
AIDS Week of Awareness (Nov 12 - 16)